Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10622	Companies
225751	Keywords
154306	Articles
119456	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 07/05/2025 at 00:00, 11 months 19 days ago

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Onco-Innovations partners with Nucro-Technics for preclinical studies on PNKP inhibitor, critical step towards human trials. Strategic collaboration with GLP and GMP experienced CRO

Clinical Trials Preclinical Studies Onco-Innovations PNKP Inhibitor Nucro-Technics
BRIEF

published on 07/03/2025 at 00:35, 11 months 21 days ago

Onco-Innovations Reveals Strategic Developments in Investor Call

Artificial Intelligence Cancer Treatment Strategic Milestones Onco-Innovations PNKP Inhibitor
BRIEF

published on 07/03/2025 at 00:35, 11 months 21 days ago

Onco-Innovations dévoile ses développements stratégiques lors d'une conférence téléphonique avec les investisseurs

Intelligence Artificielle Traitement Du Cancer Étapes Stratégiques Onco-Innovations Inhibiteur De PNKP
PRESS RELEASE

published on 07/03/2025 at 00:30, 11 months 21 days ago

Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
Onco-Innovations updates strategic roadmap for cancer treatment innovation, highlighting AI partnerships and research collaborations

Cancer Treatment Strategic Roadmap AI Partnerships Onco-Innovations Research Collaborations
BRIEF

published on 06/28/2025 at 00:05, 11 months 26 days ago

Onco-Innovations and AstraZeneca Collaboration in AI-Oncology Consortium

Cancer Research PROmAI Consortium AI Oncology AstraZeneca Partnership Causal AI
BRIEF

published on 06/28/2025 at 00:05, 11 months 26 days ago

Collaboration entre Onco-Innovations et AstraZeneca au sein du consortium IA-Oncologie

Recherche Sur Le Cancer Oncologie IA Consortium PROmAI Partenariat Avec AstraZeneca IA Causale
PRESS RELEASE

published on 06/28/2025 at 00:00, 11 months 26 days ago

Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
Onco-Innovations' Inka Health receives Expression of Interest from AstraZeneca to join PROmAI Consortium, advancing AI solutions in oncology. AstraZeneca's involvement reinforces the Consortium's mission of enhancing predictive cancer research

Oncology AstraZeneca Onco-Innovations Inka Health PROmAI Consortium
BRIEF

published on 06/26/2025 at 00:05, 11 months 28 days ago

Onco-Innovations Announces Special Investors' Conference Call

Cancer Research Onco-Innovations Thomas O'Shaughnessy July 2025 Investors' Conference
BRIEF

published on 06/26/2025 at 00:05, 11 months 28 days ago

Onco-Innovations annonce une conférence téléphonique spéciale pour les investisseurs

Conférence Des Investisseurs Recherche Sur Le Cancer Onco-Innovations Thomas O'Shaughnessy Juillet 2025
PRESS RELEASE

published on 06/26/2025 at 00:00, 11 months 28 days ago

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
Onco-Innovations Limited announces special investor conference call with CEO Thomas O'Shaughnessy on July 2, 2025. Join at link.meetingpanel.com, or via toll-free number

Patented Technology Cancer Research Investor Conference Call Onco-Innovations Limited Thomas O'Shaughnessy

Accesswire

Published on 06/24/2026 at 03:15, 5 hours 40 minutes ago

Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 8 hours 55 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 9 hours 10 minutes ago

Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 9 hours 35 minutes ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 9 hours 40 minutes ago

EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects

View all ACCESSWIRE

EQS Group

Published on 06/24/2026 at 08:39, 16 minutes ago

Sirma and Schwarz Digits Forge Strategic Alliance to Advance Sovereign Enterprise AI Across Europe
Published on 06/24/2026 at 08:30, 25 minutes ago

Restoration- Corpus Resources Plc
Published on 06/24/2026 at 08:30, 25 minutes ago

RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 22 June 2026
Published on 06/24/2026 at 08:15, 40 minutes ago

Voltage Energy Highlights Pre-Assembled Wiring Solutions at Intersolar Europe 2026
Published on 06/24/2026 at 08:00, 55 minutes ago

Orla Keegan Appointed Head of Investor Relations

Les Echos

Published on 06/23/2026 at 19:47, 13 hours 7 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 13 hours 7 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 13 hours 45 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 13 hours 45 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 14 hours 23 minutes ago

Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix

View all LES ECHOS COMFI WIRE